The Food and Drug Administration (FDA) has recently approved a weight loss option that was originally only for the severely obese.
Allergan’s Lap-Bad can not be used by individuals in the BMI (body mass index) range between 30 and 40, as long as they also have heart disease, diabetes, or a similar condition known to be caused by obesity.
This new FDA ruling now brings the total number of Americans eligible for the band close around 37 million.
The procedure to have a Lap-Band implemented includes a potentially expensive surgery. Due to that, many officials are weary as to whether or not this will help. Also, individuals may not be able to receive proper coverage for this procedure for upwards of two years.
The Lap-Band produced sales figures close to $250 million in 2010, as it dominated the gastric band market with close to 75 percent share.
Allergan believes the new approval will benefit the public, and potentially increase the health of individuals, especially those with BMI numbers greater than 35.